[1] Rasko J, Power C. (2021) Flesh Made New: The Unnatural Historty and Broken Promise of Stem Cells. HarperAudio.

[2] Sipp D, Turner L, Rasko JEJ. Stem Cell Businesses and Right to Try Laws. Cell Stem Cell 2019;5(25):304-305

[3] Rachul C, Rasko JEJ, Caulfield T. Implicit hype? Representations of platelet rich plasma in the new media. PLoS ONE 2017; 12(8): e0182496

[4] Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ. Marketing of Unproven Stem Cell-Based Interventions: A Call to Action. Science Translational Medicine 2017;9(397): e aag0426

[5] Sipp D, McCabe C, Rasko JEJ. Show drugs work before selling them. Nature 2017;8(543):174-175.

[6] Berger I, Ahmad A, Bansal A, Kapoor T, Sipp D, Rasko JEJ. Global Distribution of Businesses Marketing Stem Cell-Based Interventions. Cell Stem Cell 2016;19(2):158-162.

[7] Power C and Rasko JEJ. Promises and challenges of stem cell research for regenerative medicine. Annals of Internal Medicine 2011;155(10):706-U91.

[8] Rasko JEJ, O’Sullivan G, Ankeny R (2006). The Ethics of Inheritable Genetic Modification: A Dividing Line? Cambridge University Press.